Literature DB >> 17724295

Homoplasmy, heteroplasmy, and mitochondrial dystonia.

R McFarland1, P F Chinnery, E L Blakely, A M Schaefer, A A M Morris, S M Foster, H A L Tuppen, V Ramesh, P J Dorman, D M Turnbull, R W Taylor.   

Abstract

BACKGROUND: In clinical practice, mitochondrial disease is seldom considered until a variable combination of seizures, alteration in tone, muscle weakness, and developmental problems is evident. However, it is not uncommon for one symptom to occur in isolation and dominate the clinical phenotype. We report six patients from two families where dystonia was the principal clinical manifestation. A mitochondrial etiology was considered in each case because of the association of dystonia with other less prominent clinical features such as epilepsy.
METHODS: Histochemical and biochemical analyses were undertaken in skeletal muscle biopsies from individuals in both families. Sequencing of skeletal muscle mtDNA was also performed and suspected mutations were quantified by hot last cycle PCR-RFLP or primer extension assay. Functional consequences of one of the mutations were investigated by measurement of steady state levels of mitochondrial tRNA.
RESULTS: Two distinct mitochondrial pathologies were identified: a novel, homoplasmic mitochondrial tRNA(Cys) (MTTC) mutation and the primary, m.11778G>A Leber hereditary optic neuropathy (LHON) mutation. The mild nature of both mutations has permitted very high levels of mutated mtDNA to accumulate. Patients with the mutation in the MTTC gene have no wild type mtDNA detectable and although the LHON mutation is heteroplasmic in the patients we report, it is commonly observed to be homoplasmic.
CONCLUSIONS: The mitochondrial etiology identified in these patients emphasizes the pathologic potential of homoplasmic mutations and has important implications for the investigation and genetic counseling of families where dystonia is the principal clinical feature. We advocate that mitochondrial disease should be given serious consideration in patients with familial, progressive dystonia, particularly when additional neurologic features such as epilepsy are present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724295     DOI: 10.1212/01.wnl.0000267843.10977.4a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Novel mitochondrial C15620A variant may modulate the phenotype of mitochondrial G11778A mutation in a Chinese family with Leigh syndrome.

Authors:  Kunqian Ji; Jinfan Zheng; Baoying Sun; Fuchen Liu; Jingli Shan; Duoling Li; Yue-Bei Luo; Yuying Zhao; Chuanzhu Yan
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

2.  Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T>C.

Authors:  Russell P Saneto; Keshav K Singh
Journal:  Mitochondrion       Date:  2010-05-27       Impact factor: 4.160

Review 3.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 4.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 5.  Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes.

Authors:  Roseanne O Yeung; Fady Hannah-Shmouni; Karen Niederhoffer; Mark A Walker
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

Review 6.  Experimental therapeutics for dystonia.

Authors:  H A Jinnah; Ellen J Hess
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 7.  The inheritance of pathogenic mitochondrial DNA mutations.

Authors:  L M Cree; D C Samuels; P F Chinnery
Journal:  Biochim Biophys Acta       Date:  2009-03-19

8.  Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.

Authors:  Chaya G Bhuvaneswar; Jared L Goetz; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 9.  Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; J-M Saudubray; E Roze; Y Agid; M Vidailhet
Journal:  J Inherit Metab Dis       Date:  2008-05-30       Impact factor: 4.750

Review 10.  The mitochondrial brain: From mitochondrial genome to neurodegeneration.

Authors:  Helen E Turnbull; Nichola Z Lax; Daria Diodato; Olaf Ansorge; Doug M Turnbull
Journal:  Biochim Biophys Acta       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.